Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

Phase 1 clinical trial results evaluating the safety and pharmacokinetics of ABT-414 in patients with glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• ABT-414 (depatuxizumab mafodotin)

Snippet

Sponsor: AbbVie | Conditions: Glioblastoma Multiforme | Phase 1 | Status: COMPLETED